Sign in

CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
980542593
Phone
(877) 237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. S-4/A Deal Registration Statement - Business Combination
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. S-4/A Deal Registration Statement - Business Combination
  6. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  7. SC 13D/A Stake Beneficial Ownership Report
  8. 4 Insider Changes in Ownership
  9. UPLOAD Other SEC-generated Letter
  10. 425 Deal Prospectus/Communication re Business Combination
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. S-4/A Deal Registration Statement - Business Combination
  13. 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
  14. UPLOAD Other SEC-generated Letter
  15. S-4 Deal Registration Statement - Business Combination
  16. SC 13D/A Stake Beneficial Ownership Report
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 10-Q Report Quarterly Report
  20. SC 13D Stake Beneficial Ownership Report

Page 11 of 38 · 752 filings